Reducing cervical cancer disparities among underserved women by increasing Pap and HPV testing as well as HPV vaccination among their adolescent children
Author: Disparity Matters
Launching Initiative to Combat COVID-19 Vaccine Disparities
Investing $210+ million in scientific research on health inequities and expanding opportunities for underrepresented groups in science and medicine
Addressing cancer disparities in Nebraska by focusing on precision prevention and key risk factors specific to the state
Supporting Southern Research Program to bring genetics-driven health insights to Alabama free of charge to address healthcare disparities
A recent study published in JAMA Network Open reveals a troubling trend in hospital admission notes, where language expressing doubt about patient-reported clinical histories is more prevalent for non-Hispanic Black patients compared to their non-Hispanic White counterparts. The research, conducted at a large academic health system in the Northeast United States, analyzed 54,936 admission notes from 1,249 clinicians over a five-year period. The study found that 71% of all admission notes contained what researchers termed “doubt language” – words or phrases that cast uncertainty on a patient’s reported symptoms, experiences, or health behaviors. Alarmingly, notes about non-Hispanic Black patients had 21%…
Addressing obesity-related health disparities by tracking how frequently people visit locations that influence physical activity and food choices
Working to ensure presentation of all human brains in scientific studies
A new perspective article suggests that skin pigmentation could play a significant role in how effectively medications work, potentially leading to unintended health disparities among people with different skin tones. Researchers Simon Groen and Sophie Zaaijer argue that melanin, the pigment responsible for skin color, may act as a “sponge” for certain drugs, affecting their bioavailability and efficacy. The study, published in the journal Human Genomics, raises alarming questions about the standard dosing practices in the pharmaceutical industry. Groen, an assistant professor at the University of California, Riverside, states, “Melanin’s implications for drug safety and dosing have been largely overlooked, raising…
Launching mobile mammography to bring screening to underserved communities in Oakland